Impact of the obesity epidemic on hypertension and renal disease

被引:78
作者
Hall, JE [1 ]
Jones, DW [1 ]
Kuo, JJ [1 ]
da Silva, A [1 ]
Tallam, LS [1 ]
Liu, JK [1 ]
机构
[1] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA
关键词
D O I
10.1007/s11906-003-0084-z
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Excess weight gain is a major cause of increased blood pressure in most patients with essential hypertension, and also greatly increases the risk for renal disease. Obesity raises blood pressure by increasing renal tubular reabsorption, impairing pressure natriuresis, causing volume expansion due to activation of the sympathetic nervous system and renin-angiotensin system, and by physical compression of the kidneys, especially when visceral obesity is present. The mechanisms of sympathetic nervous system activation in obesity may be due, in part, to hyperleptinemia that stimulates the hypothalamic pro-opiomelanocortin pathway. With prolonged obesity, there may be a gradual loss of nephron, function that worsens with time and exacerbates hypertension. Weight reduction is an essential first step in the management of obesity hypertension and renal disease. Special considerations for the obese patient, in addition to adequately controlling the blood pressure, include correction of the metabolic abnormalities and protection of the kidneys from further injury.
引用
收藏
页码:386 / 392
页数:7
相关论文
共 49 条
[1]   Overweight and sympathetic overactivity in black Americans [J].
Abate, NI ;
Mansour, YH ;
Tuncel, M ;
Arbique, D ;
Chavoshan, B ;
Kizilbash, A ;
Howell-Stampley, T ;
Vongpatanasin, W ;
Victor, RG .
HYPERTENSION, 2001, 38 (03) :379-383
[2]   Pathophysiological role of leptin in obesity-related hypertension [J].
Aizawa-Abe, M ;
Ogawa, Y ;
Masuzaki, H ;
Ebihara, K ;
Satoh, N ;
Iwai, H ;
Matsuoka, N ;
Hayashi, T ;
Hosoda, K ;
Inoue, G ;
Yoshimasa, Y ;
Nakao, K .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09) :1243-1252
[3]   Sympathetic neural activation in visceral obesity [J].
Alvarez, GE ;
Beske, SD ;
Ballard, TP ;
Davy, KP .
CIRCULATION, 2002, 106 (20) :2533-2536
[4]   THE PROSPECTIVE CARDIOVASCULAR MUNSTER (PROCAM) STUDY - PREVALENCE OF HYPERLIPIDEMIA IN PERSONS WITH HYPERTENSION AND OR DIABETES-MELLITUS AND THE RELATIONSHIP TO CORONARY HEART-DISEASE [J].
ASSMANN, G ;
SCHULTE, H .
AMERICAN HEART JOURNAL, 1988, 116 (06) :1713-1724
[5]   Chronic cardiovascular and renal actions of leptin - Role of adrenergic activity [J].
Carlyle, M ;
Jones, OB ;
Kuo, JJ ;
Hall, JE .
HYPERTENSION, 2002, 39 (02) :496-501
[6]   The puzzle of hypertension in African-Americans [J].
Cooper, RS ;
Rotimi, CN ;
Ward, R .
SCIENTIFIC AMERICAN, 1999, 280 (02) :56-63
[7]   Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure [J].
Correia, MLG ;
Morgan, DA ;
Sivitz, WI ;
Mark, AL ;
Haynes, WG .
HYPERTENSION, 2001, 37 (03) :936-942
[8]   Oxidative stress in a rat model of obesity-induced hypertension [J].
Dobrian, AD ;
Davies, MJ ;
Schriver, SD ;
Lauterio, TJ ;
Prewitt, RL .
HYPERTENSION, 2001, 37 (02) :554-560
[9]   Interactions between leptin and the human sympathetic nervous system [J].
Eikelis, N ;
Schlaich, M ;
Aggarwal, A ;
Kaye, D ;
Esler, M .
HYPERTENSION, 2003, 41 (05) :1072-1079
[10]   Sympathetic nervous system and insulin resistance: From obesity to diabetes [J].
Esler, M ;
Rumantir, M ;
Wiesner, G ;
Kaye, D ;
Hastings, J ;
Lambert, G .
AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (11) :304S-309S